Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

China flag China · Delayed Price · Currency is CNY
58.12
+0.42 (0.73%)
Mar 6, 2026, 4:00 PM EST
-17.36%
Market Cap 4.64B
Revenue (ttm) 597.21M
Net Income (ttm) 222.82M
Shares Out 80.72M
EPS (ttm) 2.77
PE Ratio 20.77
Forward PE 11.62
Dividend 1.37 (2.36%)
Ex-Dividend Date Jul 9, 2025
Volume 464,490
Average Volume 431,480
Open 57.99
Previous Close 57.70
Day's Range 57.64 - 58.26
52-Week Range 55.01 - 88.96
Beta 0.38
RSI 35.21
Earnings Date Apr 23, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2010
Employees 856
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688581
Full Company Profile

Financial Performance

In 2025, Hangzhou AGS MedTech's revenue was 597.21 million, a decrease of -6.19% compared to the previous year's 636.63 million. Earnings were 222.82 million, a decrease of -24.06%.

Financial Statements

News

There is no news available yet.